drugset / Trial / NCT01548560
Assessing the Safety of Dapivirine Gel and Film Formulations
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a study to determine the safety of dapivirine gel and dapvirine film for healthy, HIV-uninfected women aged 18-45 years using the product for 7 daily doses.
Timeline
- Start
- 2012-08
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dapivirine | Small molecule | 0.5 % | Other |
| Subject | dapivirine | Small molecule | 1.25 mg | Other |
| Subject | dapivirine | Small molecule | 2.5 g | Other |